{
  "image_filename": "table_p4_det_3_003.png",
  "image_path": "Treanor_et_al.__2011_/extracted/figures/table_p4_det_3_003.png",
  "image_type": "Table",
  "page_number": 4,
  "block_id": "det_3_003",
  "claim_id": "claim_002",
  "claim": "Cell- and egg-based flu vaccines have the potential to develop mutations during production, which may reduce their effectiveness.",
  "supports_claim": false,
  "explanation": "A table presenting pre- and post-vaccination geometric mean titers (with confidence intervals) and percent response (defined as a \u22654-fold increase to \u22651:40) for placebo and multiple vaccine groups (including previously vaccinated and not previously vaccinated cohorts) against various influenza strains. The table presents immunogenicity data (antibody titers and response rates) for different vaccine formulations but does not mention or provide data on mutations arising during egg- or cell-based production or their impact on vaccine effectiveness, and therefore does not support the claim. Note: None",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "A table presenting pre- and post-vaccination geometric mean titers (with confidence intervals) and percent response (defined as a \u22654-fold increase to \u22651:40) for placebo and multiple vaccine groups (including previously vaccinated and not previously vaccinated cohorts) against various influenza strains.",
    "evidence_found": null,
    "reasoning": "The table presents immunogenicity data (antibody titers and response rates) for different vaccine formulations but does not mention or provide data on mutations arising during egg- or cell-based production or their impact on vaccine effectiveness, and therefore does not support the claim.",
    "confidence_notes": "None"
  }
}